Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses —— — Research & development —— — Operating income 85.49 M63.54 M — Non-Operating Income, Total -7.79 M23.13 M — Interest expense, net of interest capitalized 36.95 M29.26 M — Non-Operating Income, excl. Interest Expenses -39.13 M-6.13 M — Unusual income/expense -5.61 M— — Pretax income 42.93 M31.96 M — Equity in earnings —— — Taxes 10.04 M11.37 M — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 32.9 M20.6 M — Discontinued operations —— — Net income 32.9 M20.6 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 32.9 M20.6 M — Basic earnings per share (Basic EPS) 0.190.1 — Diluted earnings per share (Diluted EPS) 0.190.11 — Average basic shares outstanding 171.42 M177 M — Diluted shares outstanding 174.95 M181.44 M — EBITDA 364.41 M394.37 M — EBIT 361.14 M337.47 M — Cost of revenue —— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 3.26 M56.9 M —